The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...
FDA approves new pain pill Journavx, a non-opioid alternative to treat acute pain. Despite modest effectiveness, it shows promise in pain management.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...
Kennedy has tried to recast his anti-vaccine extremism as an honest effort to illuminate what he claims is unsettled science (it’s not). He insists he’s not trying to take away anyone’s shots; he’s ...
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback